VINZENZ GRUPPE
     
 

Clinical outcome of concomitant vs interrupted BRAF Inhibitor therapy during radiotherapy in melanoma patients.

Hecht, M, Meier, F, Zimmer, L, Polat, B, Loquai, C, Weishaupt, C, Forschner, A, Gutzmer, R, Utikal, JS, Goldinger, SM, Geier, M, Hassel, JC, Balermpas, P, Kiecker, F, Rauschenberg, R, Dietrich, U, Clemens, P, Berking, C, Grabenbauer, G, Schadendorf, D, Grabbe, S, Schuler, G, Fietkau, R, Disel, LV and Heinzerling, L (2018) Clinical outcome of concomitant vs interrupted BRAF Inhibitor therapy during radiotherapy in melanoma patients. British Journal Cancer, 118 (6). pp. 785-792.

Full text not available from this repository.
Item Type: Article
Subjects: QZ Pathologie, Onkologie
Divisions: Ordensklinikum Linz Barmherzige Schwestern > Radio-Onkologie und Strahlentherapie
Depositing User: Prof. Dr. Hans Geinitz
Date Deposited: 30 Aug 2018 07:25
Last Modified: 30 Aug 2018 07:25
URI: http://eprints.vinzenzgruppe.at/id/eprint/8335

Actions (login required)

View Item
View Item